155 related articles for article (PubMed ID: 21218351)
1. Expert elicitation for the judgment of prion disease risk uncertainties.
Tyshenko MG; ElSaadany S; Oraby T; Darshan S; Aspinall W; Cooke R; Catford A; Krewski D
J Toxicol Environ Health A; 2011; 74(2-4):261-85. PubMed ID: 21218351
[TBL] [Abstract][Full Text] [Related]
2. The risk of accidental transmission of transmissible spongiform encephalopathy: identification of emerging issues.
Ramasamy I
Public Health; 2004 Sep; 118(6):409-20. PubMed ID: 15313594
[TBL] [Abstract][Full Text] [Related]
3. [Basic research on BSE transmission to people].
Bodemer W; Kaup FJ
Dtsch Tierarztl Wochenschr; 2002 Aug; 109(8):338-41. PubMed ID: 12224460
[TBL] [Abstract][Full Text] [Related]
4. [Comments on present-day spread and epidemiology of BSE and prion diseases].
Bodemer W; Kaup FJ
Gesundheitswesen; 2004 Feb; 66 Suppl 1():S21-5. PubMed ID: 14770333
[TBL] [Abstract][Full Text] [Related]
5. [BSE, prions, vCJD and (not only) homologous transfusion].
Köhler M
Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):43-7. PubMed ID: 12522730
[No Abstract] [Full Text] [Related]
6. Transfusion transmission of human prion diseases.
Zou S; Fang CT; Schonberger LB
Transfus Med Rev; 2008 Jan; 22(1):58-69. PubMed ID: 18063192
[TBL] [Abstract][Full Text] [Related]
7. [Prion diseases. The association of bovine spongiform encephalopathy with new variant of Creutzfeldt-Jakob disease].
Calza L; Manfredi R; Marinacci G; Venturi C; Chiodo F
Ann Ital Med Int; 1998; 13(4):209-16. PubMed ID: 10349202
[TBL] [Abstract][Full Text] [Related]
8. Variant Creutzfeldt Jakob Disease.
Painter MJ
J Infect; 2000 Sep; 41(2):117-24. PubMed ID: 11023754
[No Abstract] [Full Text] [Related]
9. PrPTSE distribution in a primate model of variant, sporadic, and iatrogenic Creutzfeldt-Jakob disease.
Herzog C; Rivière J; Lescoutra-Etchegaray N; Charbonnier A; Leblanc V; Salès N; Deslys JP; Lasmézas CI
J Virol; 2005 Nov; 79(22):14339-45. PubMed ID: 16254368
[TBL] [Abstract][Full Text] [Related]
10. Molecular aspects of disease pathogenesis in the transmissible spongiform encephalopathies.
Priola SA; Vorberg I
Methods Mol Biol; 2004; 268():517-40. PubMed ID: 15156065
[TBL] [Abstract][Full Text] [Related]
11. Variant Creutzfeldt-Jakob disease: risk of transmission by blood and blood products.
Ironside JW; Head MW
Haemophilia; 2004 Oct; 10 Suppl 4():64-9. PubMed ID: 15479374
[TBL] [Abstract][Full Text] [Related]
12. Consensus statement on the bio-safety of urinary-derived gonadotrophins with respect to Creutzfeldt-Jakob disease.
Balen AH; Lumholtz IB
Hum Reprod; 2005 Nov; 20(11):2994-9. PubMed ID: 16055457
[TBL] [Abstract][Full Text] [Related]
13. An overview of prion biology and the role of blood filtration in reducing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease.
Cervia JS; Sowemimo-Coker SO; Ortolano GA; Wilkins K; Schaffer J; Wortham ST
Transfus Med Rev; 2006 Jul; 20(3):190-206. PubMed ID: 16787827
[TBL] [Abstract][Full Text] [Related]
14. Variant Creutzfeldt-Jakob disease transmission by plasma products: assessing and communicating risk in an era of scientific uncertainty.
Farrugia A; Ironside JW; Giangrande P
Vox Sang; 2005 Nov; 89(4):186-92. PubMed ID: 16262750
[TBL] [Abstract][Full Text] [Related]
15. BSE: can we predict the future?
Plum J
Bull Mem Acad R Med Belg; 1997; 152(6):264-73. PubMed ID: 9581370
[TBL] [Abstract][Full Text] [Related]
16. Manufacture of plasma-derived products in France and measures to prevent the risk of vCJD transmission: precautionary measures and efficacy of manufacturing processes in prion removal.
Flan B; Arrabal S
Transfus Clin Biol; 2007 May; 14(1):51-62. PubMed ID: 17540602
[TBL] [Abstract][Full Text] [Related]
17. The public health impact of prion diseases.
Belay ED; Schonberger LB
Annu Rev Public Health; 2005; 26():191-212. PubMed ID: 15760286
[TBL] [Abstract][Full Text] [Related]
18. Variant Creutzfeldt-Jakob disease (vCJD) and gastrointestinal endoscopy.
Axon AT; Beilenhoff U; Bramble MG; Ghosh S; Kruse A; McDonnell GE; Neumann C; Rey JF; Spencer K;
Endoscopy; 2001 Dec; 33(12):1070-80. PubMed ID: 11740649
[TBL] [Abstract][Full Text] [Related]
19. [Risk factors for sporadic Creutzfeldt-Jakob disease].
Kittner C; Heinemann U; Zerr I
Dtsch Med Wochenschr; 2009 Jul; 134(27):1429-35. PubMed ID: 19551608
[TBL] [Abstract][Full Text] [Related]
20. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
Ludlam CA; Turner ML
Br J Haematol; 2006 Jan; 132(1):13-24. PubMed ID: 16371015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
